» Authors » Yong Cheol Shin

Yong Cheol Shin

Explore the profile of Yong Cheol Shin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 102
Citations 1479
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Shin Y, Than N, Park S, Kim H
Expert Opin Drug Metab Toxicol . 2024 Jun; 20(7):593-606. PMID: 38849312
Introduction: There is a growing need for alternative models to advance current non-clinical experimental models because they often fail to accurately predict drug responses in human clinical trials. Human organ-on-a-chip...
2.
Kim J, Bae E, Park H, Park H, Shah S, Lee K, et al.
Water Res . 2023 Dec; 250:121035. PMID: 38154339
Membrane bioreactors (MBRs) play a crucial role in wastewater treatment, but they face considerable challenges due to fouling. To tackle this issue, innovative strategies are needed. This study investigated the...
3.
Park R, Kang M, Heo G, Shin Y, Han D, Hong S
ACS Nano . 2023 Dec; 18(2):1325-1344. PMID: 38099607
Micro-/nanotopographical cues have emerged as a practical and promising strategy for controlling cell fate and reprogramming, which play a key role as biophysical regulators in diverse cellular processes and behaviors....
4.
Kim D, Lee Y, Jang B, Park J, Park S, DAdamo C, et al.
Sci Rep . 2023 Nov; 13(1):20177. PMID: 37978330
Many patients in Korea use Korean Medicine (KM) after spine surgery, but related research is lacking. Therefore, this retrospective cohort study aimed to analyze factors affecting the use and costs...
5.
Kang M, Park R, Jo H, Shin Y, Kim C, Hyon S, et al.
Cells . 2023 Jun; 12(11). PMID: 37296569
In recent years, bone tissue engineering (BTE) has made significant progress in promoting the direct and functional connection between bone and graft, including osseointegration and osteoconduction, to facilitate the healing...
6.
Ku J, Kim M, Choi Y, Lee S, Im J, Jo Y, et al.
Int J Mol Sci . 2023 Apr; 24(8). PMID: 37108692
Lung cancer is one of the most common malignant tumors and a leading cause of cancer-related death in the worldwide. Various anticancer drugs, such as cisplatin and pemetrexed, have been...
7.
Min S, Than N, Shin Y, Hu G, Shin W, Ambrosini Y, et al.
Sci Rep . 2022 Dec; 12(1):22641. PMID: 36587177
Here, we report a pathomimetic Leaky Gut Chip that recapitulates increased epithelial permeability and intestinal inflammation to assess probiotic intervention as live biotherapeutics. We leveraged a mechanodynamic human gut-on-a-chip (Gut...
8.
Choi Y, Lee K, Jeong M, Shin Y, Ko S
Metabolites . 2022 Nov; 12(11). PMID: 36355120
Exosomes released from tumor cells treated with cancer-targeting drugs reflect altered metabolic processes within the cells. Therefore, metabolites in exosomes can be used as markers to predict the therapeutic response...
9.
Youn B, Moon S, Mok K, Cheon C, Ko Y, Park S, et al.
Complement Ther Med . 2022 Sep; 71:102889. PMID: 36162719
Objectives: Traditional, complementary, and alternative medicine (TC&AM) play an exceptional role in health care around the world as many patients has sought a holistic approach. Setting: In this study, a...
10.
Yoon H, Lee S, Kim T, Yu S, Kim H, Chung Y, et al.
Bioact Mater . 2022 Apr; 18:433-445. PMID: 35415304
All-in-one treatments represent a paradigm shift in future medicine. For example, inflammatory bowel disease (IBD) is mainly diagnosed by endoscopy, which could be applied for not only on-site monitoring but...